EARLIER ACCESS TO INNOVATION: ADAPTIVE LICENSING COMBINED WITH RISK SHARING - INTERIM RESULTS

• In: What’s new in industry and science? Part 2 on Thursday, 26 September 2019, 11:00-11:10
• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Presentation
• By: HOLBEIN, Baerbel (University of Bremen, Duale Hochschule Baden-Württemberg, Germany)
• Co-author(s): Baerbel Holbein: University of Bremen, Duale Hochschule Baden-Württemberg, Bremen, Bad Mergentheim, Germany
  
• Abstract:

  Background

  Risk sharing agreements (RSA) between pharmaceutical companies, health insurers and payers already exist. One crucial question is what a risk sharing model could look like if applied for the clinical trial program with adaptive licensing pathways.

  Methods

  Drugs recently approved by both FDA and EMA, particularly the new CAR T

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login